# China NMPA Drug Inspection - Zhejiang Kairun Pharmaceutical Co., Ltd. - Cefotaxime hydrochloride dispersible tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhejiang-kairun-pharmaceutical-co-ltd/8d35b2cf-50ee-4558-a8e2-42fffcfdb837/
Source feed: China

> China NMPA drug inspection for Zhejiang Kairun Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Cefotaxime hydrochloride dispersible tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Zhejiang Kairun Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Cefotaxime hydrochloride dispersible tablets
- Inspection Finding: [Check] Dissolution rate
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/zhejiang-kairun-pharmaceutical-co-ltd/e29fd4a7-f668-463e-a3e5-a7fb0a672d43/